Lipocine Inc. (LPCN)
NASDAQ · Healthcare
Lipocine Inc. EBITDA 2012–2025
Lipocine Inc. annual/quarterly ebitda history and growth rate from 2012 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Lipocine Inc. ebitda for the quarter ending March 31, 2026 was -3.8 M, a 84.84% increase year-over-year.
- Lipocine Inc. ebitda for the twelve months ending March 31, 2026 was -7.0 M.
- Lipocine Inc. annual ebitda for 2025 was -10.3 M, a 825.61% increase from 2024.
- Lipocine Inc. annual ebitda for 2024 was -1.1 M, a 93.78% decrease from 2023.
- Lipocine Inc. annual ebitda for 2023 was -17.9 M, a 47.83% increase from 2022.
- Lipocine Inc. annual ebitda for 2022 was -12.1 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lipocine Inc. EBITDA — FAQ
Lipocine Inc. (LPCN) ebitda over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LPCN's ebitda history?
The chart and table above show Lipocine Inc.'s ebitda by year and by quarter, including the growth rate.